BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24898025)

  • 1. In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654.
    Barret O; Thomae D; Tavares A; Alagille D; Papin C; Waterhouse R; McCarthy T; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
    J Nucl Med; 2014 Aug; 55(8):1297-304. PubMed ID: 24898025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
    Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
    J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of 2-(2-(3-(4-([
    Mori W; Yamasaki T; Fujinaga M; Ogawa M; Zhang Y; Hatori A; Xie L; Kumata K; Wakizaka H; Kurihara Y; Ohkubo T; Nengaki N; Zhang MR
    J Med Chem; 2019 Jan; 62(2):688-698. PubMed ID: 30516998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [
    Svedberg MM; Varnäs K; Varrone A; Mitsios N; Mulder J; Gulyás B; Beaumont V; Munoz-Sanjuan I; Zaleska MM; Schmidt CJ; Halldin C; Mrzljak L
    Brain Res; 2019 May; 1711():140-145. PubMed ID: 30664847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization in humans of 18F-MNI-444, a PET radiotracer for brain adenosine 2A receptors.
    Barret O; Hannestad J; Vala C; Alagille D; Tavares A; Laruelle M; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
    J Nucl Med; 2015 Apr; 56(4):586-91. PubMed ID: 25698783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18F]AMG 580 in non-human primates.
    Hwang DR; Hu E; Allen JR; Davis C; Treanor J; Miller S; Chen H; Shi B; Narayanan TK; Barret O; Alagille D; Yu Z; Slifstein M
    Nucl Med Biol; 2015 Aug; 42(8):654-63. PubMed ID: 25935386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic modeling, test-retest, and dosimetry of 123I-MNI-420 in humans.
    Tavares AA; Batis JC; Papin C; Jennings D; Alagille D; Russell DS; Vala C; Lee H; Baldwin RM; Zubal IG; Marek KL; Seibyl JP; Barret O; Tamagnan GD
    J Nucl Med; 2013 Oct; 54(10):1760-7. PubMed ID: 23970369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
    Russell DS; Barret O; Jennings DL; Friedman JH; Tamagnan GD; Thomae D; Alagille D; Morley TJ; Papin C; Papapetropoulos S; Waterhouse RN; Seibyl JP; Marek KL
    JAMA Neurol; 2014 Dec; 71(12):1520-8. PubMed ID: 25322077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10A.
    Celen S; Koole M; Ooms M; De Angelis M; Sannen I; Cornelis J; Alcazar J; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
    Neuroimage; 2013 Nov; 82():13-22. PubMed ID: 23664955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D
    Fazio P; Schain M; Mrzljak L; Amini N; Nag S; Al-Tawil N; Fitzer-Attas CJ; Bronzova J; Landwehrmeyer B; Sampaio C; Halldin C; Varrone A
    Neuroimage; 2017 May; 152():330-339. PubMed ID: 28254508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between [
    Mori W; Takei M; Furutsuka K; Fujinaga M; Kumata K; Muto M; Ohkubo T; Hashimoto H; Tamagnan G; Higuchi M; Kawamura K; Zhang MR
    Nucl Med Biol; 2017 Dec; 55():12-18. PubMed ID: 28972915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjects.
    Delnomdedieu M; Forsberg A; Ogden A; Fazio P; Yu CR; Stenkrona P; Duvvuri S; David W; Al-Tawil N; Vitolo OV; Amini N; Nag S; Halldin C; Varrone A
    Neuropharmacology; 2017 May; 117():171-181. PubMed ID: 28122201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-body biodistribution and dosimetry estimates of a novel radiotracer for imaging of serotonin 4 receptors in brain: [¹⁸F]MNI-698.
    Tavares AA; Caillé F; Barret O; Papin C; Lee H; Morley TJ; Fowles K; Holden D; Seibyl JP; Alagille D; Tamagnan GD
    Nucl Med Biol; 2014; 41(5):432-9. PubMed ID: 24674817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging.
    Russell DS; Jennings DL; Barret O; Tamagnan GD; Carroll VM; Caillé F; Alagille D; Morley TJ; Papin C; Seibyl JP; Marek KL
    Neurology; 2016 Feb; 86(8):748-54. PubMed ID: 26802091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.
    Celen S; Koole M; De Angelis M; Sannen I; Chitneni SK; Alcazar J; Dedeurwaerdere S; Moechars D; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
    J Nucl Med; 2010 Oct; 51(10):1584-91. PubMed ID: 20847170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Evaluation and Quantification of
    Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
    J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial characterization of a PDE10A selective positron emission tomography tracer [11C]AMG 7980 in non-human primates.
    Hwang DR; Hu E; Rumfelt S; Easwaramoorthy B; Castrillon J; Davis C; Allen JR; Chen H; Treanor J; Abi-Dargham A; Slifstein M
    Nucl Med Biol; 2014 Apr; 41(4):343-9. PubMed ID: 24607437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of carbon-11 and fluorine-18 labeled tracers for in vivo visualization of PDE10A.
    Ooms M; Celen S; Koole M; Langlois X; Schmidt M; De Angelis M; Andrés JI; Verbruggen A; Van Laere K; Bormans G
    Nucl Med Biol; 2014 Sep; 41(8):695-704. PubMed ID: 25002365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
    Varrone A; Stepanov V; Nakao R; Tóth M; Gulyás B; Emond P; Deloye JB; Vercouillie J; Stabin MG; Jonsson C; Guilloteau D; Halldin C
    J Nucl Med; 2011 Aug; 52(8):1313-21. PubMed ID: 21764797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase 10A in the brain of living subject.
    Liu H; Jin H; Yue X; Zhang X; Yang H; Li J; Flores H; Su Y; Perlmutter JS; Tu Z
    Neuroimage; 2015 Nov; 121():253-62. PubMed ID: 26216275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.